相似文献
1
A Cycloaddition Strategy for Use toward Berkelic Acid, an MMP Inhibitor and Potent Anticancer Agent Displaying a Unique Chroman Spiroketal Motif.
Synlett. 2008 May 11;9:1353-1356. doi: 10.1055/s-2008-1072750.
2
A diastereoselective formal synthesis of berkelic acid.
Org Lett. 2011 Jan 7;13(1):118-21. doi: 10.1021/ol102652t. Epub 2010 Dec 7.
3
New strategies for natural products containing chroman spiroketals.
Pure Appl Chem. 2012;84(7):1621-1631. doi: 10.1351/PAC-CON-11-10-34.
4
Diastereoselective syntheses of chroman spiroketals via [4 + 2] cycloaddition of enol ethers and o-quinone methides.
Org Lett. 2008 Apr 3;10(7):1477-80. doi: 10.1021/ol8003244. Epub 2008 Mar 13.
5
Mechanistic Insights on Pd-Catalyzed Three-Component Reactions of Alkynols, Methyl Orthoformate, and Salicylaldehyde Derivatives. Application to the Synthesis of Steroid Chroman Ketals and Spiroketals with Antioxidant Activity.
J Org Chem. 2023 Nov 3;88(21):14860-14873. doi: 10.1021/acs.joc.3c00857. Epub 2023 Oct 25.
6
A biosynthetically inspired synthesis of (-)-berkelic acid and analogs.
Tetrahedron. 2018 Mar 1;74(9):909-919. doi: 10.1016/j.tet.2018.01.021. Epub 2018 Jan 12.
7
Total syntheses of ent-heliespirones A and C.
J Org Chem. 2012 Jan 6;77(1):379-87. doi: 10.1021/jo201971g. Epub 2011 Nov 29.
8
Organocatalytic Asymmetric [2 + 4] Cycloadditions of 3-Vinylindoles with -Quinone Methides.
Molecules. 2021 Nov 8;26(21):6751. doi: 10.3390/molecules26216751.
9
Formal synthesis of berkelic acid: a lesson in α-alkylation chemistry.
J Org Chem. 2012 Jan 6;77(1):400-16. doi: 10.1021/jo201988m. Epub 2011 Nov 28.
10
-Quinone Methide Driven Synthesis of New ,- or ,-Heterocycles.
ChemistryOpen. 2019 Jul 16;8(7):961-971. doi: 10.1002/open.201900150. eCollection 2019 Jul.
引用本文的文献
1
A biosynthetically inspired synthesis of (-)-berkelic acid and analogs.
Tetrahedron. 2018 Mar 1;74(9):909-919. doi: 10.1016/j.tet.2018.01.021. Epub 2018 Jan 12.
2
Multicomponent Condensation Reactions via ortho-Quinone Methides.
Org Lett. 2017 Apr 7;19(7):1878-1881. doi: 10.1021/acs.orglett.7b00647. Epub 2017 Mar 30.
3
New strategies for natural products containing chroman spiroketals.
Pure Appl Chem. 2012;84(7):1621-1631. doi: 10.1351/PAC-CON-11-10-34.
4
The domestication of ortho-quinone methides.
Acc Chem Res. 2014 Dec 16;47(12):3655-64. doi: 10.1021/ar500330x. Epub 2014 Dec 3.
5
A diastereoselective formal synthesis of berkelic acid.
Org Lett. 2011 Jan 7;13(1):118-21. doi: 10.1021/ol102652t. Epub 2010 Dec 7.
6
A concise synthesis of berkelic acid inspired by combining the natural products spicifernin and pulvilloric acid.
J Am Chem Soc. 2009 Aug 19;131(32):11350-2. doi: 10.1021/ja905387r.
7
Introduction of the (-)-berkelic acid side chain and assignment of the C-22 stereochemistry.
J Org Chem. 2009 Aug 21;74(16):6245-52. doi: 10.1021/jo901221a.
8
Synthesis of (-)-berkelic acid.
Angew Chem Int Ed Engl. 2009;48(7):1283-6. doi: 10.1002/anie.200805488.
本文引用的文献
1
Biomimetic synthesis of the tetracyclic core of berkelic acid.
Org Lett. 2007 May 24;9(11):2071-4. doi: 10.1021/ol0704338. Epub 2007 Apr 28.
2
Berkelic acid, a novel spiroketal with selective anticancer activity from an acid mine waste fungal extremophile.
J Org Chem. 2006 Jul 7;71(14):5357-60. doi: 10.1021/jo060018d.
3
Towards third generation matrix metalloproteinase inhibitors for cancer therapy.
Br J Cancer. 2006 Apr 10;94(7):941-6. doi: 10.1038/sj.bjc.6603043.
4
Structural basis for the highly selective inhibition of MMP-13.
Chem Biol. 2005 Feb;12(2):181-9. doi: 10.1016/j.chembiol.2004.11.014.
5
Making a new turn in matrix metalloprotease inhibition.
Chem Biol. 2005 Feb;12(2):143-4. doi: 10.1016/j.chembiol.2005.01.008.
6
Enantioselective [4 + 2] cycloadditions of o-quinone methides: total synthesis of (+)-mimosifoliol and formal synthesis of (+)-tolterodine.
J Org Chem. 2004 Dec 24;69(26):9196-203. doi: 10.1021/jo048703c.
7
Diastereoselective dearomatization of resorcinols directed by a lactic acid tether: unprecedented enantioselective access to p-quinols.
Org Lett. 2004 May 13;6(10):1535-8. doi: 10.1021/ol0498592.
8
Matrix metalloproteinases in cancer.
Essays Biochem. 2002;38:21-36. doi: 10.1042/bse0380021.
9
Critical appraisal of the use of matrix metalloproteinase inhibitors in cancer treatment.
Oncogene. 2000 Dec 27;19(56):6642-50. doi: 10.1038/sj.onc.1204097.
Zotero 插件